昆药集团(600422.SH)2025年度归母净利润预计3.5亿元同比下降46%

智通财经网02-06 17:18

智通财经APP讯，昆药集团(600422.SH)披露2025年度业绩快报，公司累计实现营业收入预计65.77亿元，较上年同期下降21.72%;实现归母净利润预计3.5亿元，同比下降46%。

报告期，公司产品销售规模及毛利率同比均有所回落。公司非经常性损益预计为2.43亿元，同比增加6.1%，主要系参股企业南京维立志博生物科技股份有限公司港股上市带动公司持有的相关金融资产公允价值变动损益及投资收益同比显著增长，预计金额为1.19亿元;此外，计入当期损益的政府补助约0.7亿元，同比下降24.15%。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2609934566?lang=zh_CN&edition=full","thumbnail":"https://img.zhitongcaijing.com/astock/3.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","is_english":false,"pubTime":"2026-02-06 17:18","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2609934566","market":"us","top_or_hot":-1,"title":"昆药集团(600422.SH)2025年度归母净利润预计3.5亿元 同比下降46%","media":"智通财经网","content":"<html><body><div> <p>智通财经APP讯，<a href=\"https://laohu8.com/S/600422\">昆药集团</a>(600422.SH)披露2025年度业绩快报，公司累计实现营业收入预计65.77亿元，较上年同期下降21.72%;实现归母净利润预计3.5亿元，同比下降46%。</p><p>报告期，公司产品销售规模及毛利率同比均有所回落。公司非经常性损益预计为2.43亿元，同比增加6.1%，主要系参股企业南京维立志博生物科技股份有限公司港股上市带动公司持有的相关金融资产公允价值变动损益及投资收益同比显著增长，预计金额为1.19亿元;此外，计入当期损益的政府补助约0.7亿元，同比下降24.15%。</p> <div></div> </div></body></html>","source":"highlight_zhitongcaijin","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昆药集团(600422.SH)2025年度归母净利润预计3.5亿元 同比下降46%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昆药集团(600422.SH)2025年度归母净利润预计3.5亿元 同比下降46%\n</h2>\n\n<h4 class=\"meta\">\n\n<p class=\"head\">\n<strong class=\"h-name small\">智通财经网</strong><span class=\"h-time small\">2026-02-06 17:18</span>\n</p>\n\n</h4>\n\n</header>\n<article>\n<html><body><div> <p>智通财经APP讯，<a href=\"https://laohu8.com/S/600422\">昆药集团</a>(600422.SH)披露2025年度业绩快报，公司累计实现营业收入预计65.77亿元，较上年同期下降21.72%;实现归母净利润预计3.5亿元，同比下降46%。</p><p>报告期，公司产品销售规模及毛利率同比均有所回落。公司非经常性损益预计为2.43亿元，同比增加6.1%，主要系参股企业南京维立志博生物科技股份有限公司港股上市带动公司持有的相关金融资产公允价值变动损益及投资收益同比显著增长，预计金额为1.19亿元;此外，计入当期损益的政府补助约0.7亿元，同比下降24.15%。</p> <div></div> </div></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"http://www.zhitongcaijing.com/content/detail/1402580.html\">智通财经网</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600422","symbol_name":"昆药集团","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1402580.html","article_id":"2609934566","we_media_id":null,"thumbnails":["https://img.zhitongcaijing.com/astock/3.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2609934566","pubTimestamp":1770369517,"columns":[],"sourceInfo":{"source_id":"highlight_zhitongcaijin","name":"智通财经网"},"weMediaInfo":null,"summary":"昆药集团(600422.SH)披露2025年度业绩快报，公司累计实现营业收入预计65.77亿元，较上年同期下降21.72%;实现归母净利润预计3.5亿元，同比下降46%。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"600422":"昆药集团"},"translate_title":"Kunyao Group (600422. SH) 's net profit attributable to the parent company in 2025 is expected to be 350 million yuan, a year-on-year decrease of 46%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600422":1.5},"content_text":"智通财经APP讯，昆药集团(600422.SH)披露2025年度业绩快报，公司累计实现营业收入预计65.77亿元，较上年同期下降21.72%;实现归母净利润预计3.5亿元，同比下降46%。报告期，公司产品销售规模及毛利率同比均有所回落。公司非经常性损益预计为2.43亿元，同比增加6.1%，主要系参股企业南京维立志博生物科技股份有限公司港股上市带动公司持有的相关金融资产公允价值变动损益及投资收益同比显著增长，预计金额为1.19亿元;此外，计入当期损益的政府补助约0.7亿元，同比下降24.15%。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2609934566","isCrawlerRequest":true}

昆药集团(600422.SH)2025年度归母净利润预计3.5亿元 同比下降46%

精彩评论

昆药集团(600422.SH)2025年度归母净利润预计3.5亿元同比下降46%